Literature DB >> 7564810

Salbutamol in the treatment of asthma.

M Perrin-Fayolle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564810     DOI: 10.1016/s0140-6736(95)91775-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Enantiomeric disposition of inhaled, intravenous and oral racemic-salbutamol in man--no evidence of enantioselective lung metabolism.

Authors:  J K Ward; J Dow; N Dallow; P Eynott; S Milleri; G P Ventresca
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

Review 2.  The pharmacokinetics of levosalbutamol: what are the clinical implications?

Authors:  D W Boulton; J P Fawcett
Journal:  Clin Pharmacokinet       Date:  2001-01       Impact factor: 6.447

3.  Comparative pharmacokinetics and bile transformation of R-enantiomer and racemic bambuterol after single-dose intravenous, oral administration in rats and beagle dogs.

Authors:  Su Guan; Chun-Yun Hu; Meng-Ying He; Ying-Ying Yang; Yu-Xin Tang; Jie-di Chen; Li-Jie Huang; Wen Tan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-10-04       Impact factor: 2.441

4.  Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine.

Authors:  D W Cockcroft; V A Swystun
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

5.  Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.

Authors:  B J Lipworth; D J Clark; P Koch; C Arbeeny
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

Review 6.  Drug therapy approaches in the treatment of acute severe asthma in hospitalised children.

Authors:  L K DeNicola; M O Gayle; K V Blake
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 7.  Beta2-agonists and bronchial hyperresponsiveness.

Authors:  Clive P Page; Domenico Spina
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

Review 8.  Levalbuterol for asthma: a better treatment?

Authors:  H William Kelly
Journal:  Curr Allergy Asthma Rep       Date:  2007-07       Impact factor: 4.806

Review 9.  Single-isomer levalbuterol: a review of the acute data.

Authors:  Richard Nowak
Journal:  Curr Allergy Asthma Rep       Date:  2003-03       Impact factor: 4.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.